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a b s t r a c t
We previously reported that melanocortins afford cardioprotection in conditions of experimental
myocardial ischemia/reperfusion, with involvement of the janus kinases (JAK), extracellular signal-
regulated kinases (ERK) and signal transducers and activators of transcription (STAT) signalings. We
investigated the influence of the melanocortin analog [Nle4, D-Phe7]α-melanocyte-stimulating hormone
(NDP-α-MSH) on short-term detrimental responses to cardiac arrest (CA) induced in rats by intravenous
(i.v.) administration of potassium chloride, followed by cardiopulmonary resuscitation (CPR) plus
epinephrine treatment. In CA/CPR rats i.v. treated with epinephrine (0.1 mg/kg) and returned to
spontaneous circulation (48%) we recorded low values of mean arterial pressure (MAP) and heart rate
(HR), alteration of hemogasanalysis parameters, left ventricle low expression of the cardioprotective
transcription factors pJAK2 and pTyr-STAT3 (JAK-dependent), increased oxidative stress, up-regulation of
the inflammatory mediators tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), and down-
regulation of the anti-inflammatory cytokine IL-10, as assessed at 1 h and 3 h after CPR. On the other
hand, i.v. treatment during CPR with epinephrine plus NDP-α-MSH (340 μg/kg) almost completely
restored the basal conditions of MAP and HR, reversed metabolic acidosis, induced left ventricle up-
regulation of pJAK2, pTyr-STAT3 and IL-10, attenuated oxidative stress, down-regulated TNF-α and IL-6
levels, and improved survival rate by 81%. CA/CPR plus epinephrine alone or in combination with NDP-α-
MSH did not affect left ventricle pSer-STAT3 (ERK1/2-dependent) and pERK1/2 levels. These results
indicate that melanocortins improve return to spontaneous circulation, reverse metabolic acidosis, and
inhibit heart oxidative stress and inflammatory cascade triggered by CA/CPR, likely via activation of the
JAK/STAT signaling pathway.
& 2014 Elsevier B.V. All rights reserved.
1. Introduction
Cardiac arrest (CA) remains a major health problem worldwide
and, although advances in cardiopulmonary resuscitation (CPR) are
able to improve return to spontaneous circulation, only less than
30% of patients are discharged alive from hospital (Nichol et al.,
2008; Parnia et al., 2014; Rea et al., 2004; Thom et al., 2006).
Generally, these patients die for brain and cardiovascular damage, as
a consequence of global ischemia/reperfusion injuries, and a high
percentage of survivors have moderate to severe cognitive deficits in
the months following resuscitation (Chang et al., 2007; Peberdy
et al., 2010). Epinephrine is routinely used during chest compression
to improve return to spontaneous circulation, being able to augment
both aortic diastolic and coronary perfusion pressures (Lin et al.,
2014; Ornato, 2008; Paradis et al., 1991). However, epinephrine
exacerbates myocardial ischemia/reperfusion injury and post-
resuscitation heart dysfunction by increasing myocardial oxygen
demand, and it fails to improve survival and neurological outcome
to hospital discharge (Lin et al., 2014; Yu et al., 2013).
In CA patients, brain and heart damage occurring during
ischemia and reperfusion are due to free radical discharge,
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inflammatory and apoptotic responses (Chalkias and Xanthos,
2012; Lee et al., 2012; Meybohm et al., 2009; Norman et al.,
2011). Besides further studies on therapeutic hypothermia –
mainly known as efficient treatment for neuroprotection during
CA – novel approaches to protect the heart and brain are under
investigation, including hydrogen sulfide donors, activators of
cholinergic pathways, carvedilol, and argon (Brücken et al., 2014;
Kida et al., 2012; Kurita et al., 2010; Lee et al., 2012; Norman et al.,
2011; Parnia et al., 2014; Yu et al., 2013).
The endogenous peptides melanocortins, namely adrenocorti-
cotropin/melanocyte-stimulating hormone (ACTH/MSH) group
[ACTH-(1-24), α-MSH, and shorter fragments] (Catania et al.,
2004; Corander et al., 2009; Giuliani et al., 2012; Wikberg and
Mutulis, 2008), as well as synthetic analogs, exert cardioprotective
effects. These neuropeptides have been shown to attenuate free
radical discharge, inflammatory and apoptotic responses induced
by myocardial ischemia/reperfusion in rats and mice, to stimulate
anti-apoptotic reactions, and to reduce reperfusion-induced
arrhythmias as well as infarct size (Bazzani et al., 2002; Getting
et al., 2006; Mioni et al., 2003, 2005; Ottani et al., 2010). Further,
melanocortins have a resuscitating effect during respiratory arrest
and hemorrhagic shock, and afford neuroprotection in conditions
of global and focal brain ischemia (Bertolini et al., 1989; Giuliani
et al., 2007b, 2012; Guarini et al., 1997a). Recently we have shown
that janus kinases (JAK), extracellular signal-regulated kinases
(ERK) and signal transducers and activators of transcription (STAT)
– signaling pathways that play an established cardioprotective role
(Bolli et al., 2011; Minamino, 2012; Obana et al., 2012; Xuan et al.,
2001, 2005) – are involved in the cardioprotective effect of
melanocortins against ischemia/reperfusion-induced damage
(Ottani et al., 2013).
Overall, these findings led us to hypothesize that melanocortins
could improve resuscitation and/or induce cardioprotection also in
conditions of CA. Here we investigated, therefore, the effect of the
melanocortin analog [Nle4, D-Phe7]α-MSH (NDP-α-MSH) in com-
bination with epinephrine in a rat model of CA followed by CPR,
focusing our study on resuscitation success, metabolic acidosis,
JAK/ERK/STAT signaling, oxidative stress, inflammatory and apop-
totic responses.
2. Materials and methods
2.1. Animals, surgery and cardiac arrest induction
Adult male Sprague–Dawley rats (Charles River, Milan, Italy),
weighing 400–450 g, were used. They were kept in air conditioned
colony rooms (temperature 2171 1C; humidity 60%) on a natural
light/dark cycle, with food in pellets and tap water available ad
libitum. Housing conditions and experimental procedures were in
strict accordance with the European Community regulations on
the use and care of animals for scientific purposes (CEE Council 89/
609; Italian D.L. 22-1-92 No. 116), and were approved by the
Animal Ethics Committee of Modena and Reggio Emilia University.
Under general anesthesia (urethane, 1.25 g/kg intraperitone-
ally) and after heparinization (heparin sodium, 600 iu/kg intrave-
nously; i.v.), rats were fixed in the supine position on a heated
operating platform, so to maintain rectal temperature close to
37 1C; this procedure was adopted to avoid wrong interpretation
of data due to a possible protective role of hypothermia (Lee et al.,
2012; Norman et al., 2011). Rats were instrumented with indwel-
ling polyethylene catheters in a common carotid artery, to record
arterial blood pressure, and into an iliac vein for treatments and
blood sampling. The arterial catheter was connected to a pressure
transducer coupled to a Surveyor apparatus (Mortara-Rangoni,
Bologna, Italy), as previously described (Guarini et al., 1996, 1997a,
1997b, 2003). After cannulation of the trachea the animals were
ventilated with room air by means of a respirator for small rodents
with a stroke volume of approximately 20 ml/kg and a rate of
70 strokes/min; these ventilation parameters maintained arterial
pO2, pCO2 and pH close to the normal range (Mioni et al., 2003,
2005; Ottani et al., 2010, 2013). The lead II electrocardiogram
(ECG) was recorded by means of needle electrodes placed sub-
cutaneously on the limbs and connected to the Surveyor appara-
tus, as previously described (Mioni et al., 2003, 2005; Ottani et al.,
2010, 2013). Arterial blood pressure and ECG were continuously
monitored in all animals until kill (3 h after return to spontaneous
circulation).
After a 10 min equilibration period, CA was induced by i.v.
administration of 70 mg/kg potassium chloride (KCl) dissolved in
saline (1 ml/kg) and mechanical ventilator turning off, and was
confirmed by loss of arterial pressure and asystolic rhythm on ECG
(Angelos et al., 2011; Kida et al., 2012; Norman et al., 2011). After a
5 min arrest time, chest compressions were delivered by using two
fingers at a rate of 200–220 beats/min until resuscitation (and for a
maximum of 7 min) followed by resumption of mechanical venti-
lation; rats not resuscitated within 7 min were discarded. One
minute after starting CPR, epinephrine alone or epinephrine plus
NDP-α-MSH were i.v. bolus injected, as detailed in Section 2.2. Also
animals resuscitated but not surviving at the 3 h observation
period were discarded. Sham CA/CPR rats were subjected to all
surgical procedures experienced by CA/CPR animals, but saline
instead of KCl was administered.
2.2. Drugs, treatments and experimental groups
NDP-α-MSH, synthetic melanocortin analog with long-lasting
biological activity (Giuliani et al., 2006, 2007a, 2007b, 2009; Ottani
et al., 2010, 2013) (kindly provided by Prof. Paolo Grieco, University
of Naples Federico II), and epinephrine (S.A.L.F., Cenate Sotto, Italy)
were used. Epinephrine was administered at the dose of 0.1 mg/kg
(Angelos et al., 2011; Yu et al., 2013), whereas the dose of NDP-α-
MSH (340 mg/kg) was chosen on the basis of previous experiments
performed in our laboratory in rats subjected to myocardial
ischemia/reperfusion (Ottani et al., 2010, 2013). Both drugs were
freshly dissolved in saline immediately before use and injections
were performed i.v., in a volume of 1 ml/kg, 1 min after starting CPR
(epinephrine followed by the immediate delivery of NDP-α-MSH).
Animals were randomly assigned to the following experimental
groups: 1) sham CA/CPRþsaline; 2) CA/CPRþsaline; 3) CA/
CPRþepinephrine; 4) CA/CPRþepinephrineþNDP-α-MSH; 5) sham
CA/CPRþepinephrineþNDP-α-MSH. Because of the very low survi-
val rate (14%) in this experimental model of CA/CPR, the experi-
mental control group of CA/CPR rats treated with saline was only
used for evaluating survival.
2.3. Hemogasanalysis and other blood measurements
Measurements were performed in rats of all experimental
groups. Blood samples (0.3 ml) were taken from the venous
catheter just before CA (basal conditions), 1 and 3 h after CPR,
and analyzed for pH, oxygen partial pressure (PO2), carbon dioxide
partial pressure (PCO2), bicarbonate (HCO

3 ), standard base excess
(SBE), oxygen saturation (SO2), lactate, hematocrit (Hct), Naþ ,
Ca2þ and Kþ by using an ABL90 FLEX analyzer (Radiometer
Medical ApS, Brønshøj, Denmark).
2.4. Assay of malondialdehyde concentration
Oxidative stress was assessed in the left ventricle by measuring
concentration of malondialdehyde (MDA; marker of lipid peroxidation
index) using a colorimetric commercial kit (Lipid peroxidation assay
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kit, Calbiochem, San Diego, CA) (Giuliani et al., 2014). Briefly, at the end
of the 3 h period of return to spontaneous circulation, in rats of each
group the left ventricle was removed under deep anesthesia. In 6 rats
per group, left ventricle was blotted dry and then weighed. After
centrifugation of the left ventricle lysate, 0.65 ml of 10.3 mM N-
methyl-2phenyl-indole in acetonitrile were added to 0.2 ml of the
supernatant. After vortexing for 3–4 s and adding 0.15 ml of HCl 37%,
samples were mixed well and closed with a tight stopper and
incubated at 45 1C for 60 min. The samples were then cooled on ice
and optical density was spectrophotometrically measured at 532 nm
(340 ATTC; SLT Lab Instruments, Grödig, Austria). MDA concentration
was calculated from a standard curve established with serial dilutions
of tetraethoxypropane, and expressed as nmol/g of tissue.
2.5. Isolation of cytoplasmatic proteins and Western blot analysis
At the end of the 3 h period of return to spontaneous circulation, in
the remaining rats (7–10 per group) the left ventricle was used for
Western blot analysis. Isolation of cytoplasmatic proteins and Western
blot analysis were performed as previously described (Giuliani et al.,
2006; Ottani et al., 2010, 2013). Briefly, after homogenization in lysis
buffer and centrifugation at 15,000g for 15 min, the supernatant was
collected and employed for protein determination using the BioRad
Protein Assay Kit (BioRad, Richmond, USA). Cytoplasmatic proteins
were denatured in reducing buffer and separated by electrophoresis,
and the separated proteins (40 μg for each sample) were transferred
onto polyvinylidene fluoride membranes using a transfer buffer.
Staining of the blots with Ponceau's solution showed that total protein
amount was equal in each lane. The membranes were then blocked,
washed and incubated with a primary antibody for phosphorylated (p:
active form) pJAK2, pERK1/2, pTyr-STAT3 and pSer-STAT3, total JAK,
total ERK1/2, total STAT3, tumor necrosis factor-α (TNF-α), interleukin-
6 (IL-6), BAX and active caspase-3 (Cell Signaling, Charlottesville, VA),
and IL-10 (Epitomics, Burlingame, CA), overnight at 4 1C. The day after,
the membranes were washed three times and incubated with a
specific secondary antibody peroxidase-conjugated (Cell Signaling)
for 1 h at room temperature. To prove equal loading, the blots were
analyzed for β-tubulin expression (house-keeping gene) using an anti-
β-tubulin antibody (Cell Signaling). The membranes were analyzed by
the enhanced chemiluminescence's system according to the manu-
facturer's protocol (Millipore, Billerica, MA). Protein signals were
quantified by scanning densitometry using a bio-image analysis
system (Bio-Profil, Celbio, Italy) (Ottani et al., 2010, 2013). The level/
activity of all markers was expressed as relative integrated intensity
normalized versus β-tubulin (¼100). The JAK, ERK1/2, Tyr-STAT3 and
Ser-STAT3 signals are shown as the ratio of the integrated intensity of
phosphorylated vs unphosphorylated form.
2.6. Statistical analysis
All data were collected and analyzed blind to the treatment.
Survival rates were compared by Fisher's exact probability test. Mean
arterial pressure (MAP) and heart rate (HR) values, and hemogasana-
lysis/blood parameters, were analyzed by means of two-way repeated
measures ANOVA followed by Student–Newman–Keuls' test. One-way
ANOVA followed by Student–Newman–Keuls' test was used for all
other data. A P value o0.05 was considered significant.
3. Results
3.1. NDP-α-MSH improves return to spontaneous circulation
In all experimental groups, a part of rats undergone CA
returned to spontaneous circulation within 2–4 min of chest
compression, whereas a part died for CPR failure or within 30–
60 min after CPR. Specifically, at the end of the 3 h period of return
to spontaneous circulation, CPR was associated with a 14% survival
in saline-treated rats, statistically different from that observed in
epinephrine-treated animals (48%) (Table 1). Furthermore, survival
rate increased significantly to 81% when NDP-α-MSH was asso-
ciated with epinephrine (Table 1). Treatment of sham CA/CPR
animals with i.v. epinephrine plus NDP-α-MSH did not affect
survival (100%).
During CA, in all rats there was a loss of arterial pressure and
asystolic rhythm on ECG, and after success CPR a progressive and
almost complete restoration in MAP and HR, above all in epi-
nephrine- plus NDP-α-MSH-treated animals (Fig. 1). Treatment of
sham animals with i.v. epinephrine plus NDP-α-MSH did not affect
MAP nor HR (n¼9, not shown). Obviously, MAP and HR values, as
well as all the following reported data, refer only to animals
surviving at 3 h after CPR.
3.2. NDP-α-MSH restores basal conditions of hemogasanalysis
parameters
In epinephrine-treated rats, CA/CPR caused significant changes
in pH, PO2, PCO2, HCO

3 , SBE and SO2 values, as recorded at 1 h and
3 h after CPR (Table 2). At the same time points, significant
alterations of Hct, lactate, Naþ and Ca2þ blood levels were not
found in our CA/CPR model; on the contrary, Kþ concentration
increased in epinephrine-treated CA/CPR rats (seemingly due to
KCl injection) (Table 2). Treatment with epinephrine plus NDP-α-
MSH almost completely restored the basal values of hemogasana-
lysis parameters within 1 h after CPR, the values remaining stable
up to the 3 h observation period (Table 2). Treatment of sham
animals with i.v. epinephrine plus NDP-α-MSH did not alter
hemogasanalysis parameters (n¼9, not shown).
3.3. NDP-α-MSH activates JAK/STAT signaling in the heart
Western blot analysis at the end of the 3 h observation period
showed, in the left ventricle of epinephrine-treated CA/CPR rats, a
mild expression of the active pJAK2 and pTyr-STAT3 (which is
pJAK2-dependent), but neither pERK1/2 nor pSer-STAT3 (pERK1/
2-dependent) were affected (Fig. 2). In rats treated, during CPR,
with epinephrine plus NDP-α-MSH there was a significantly
increased expression of pJAK2 and pTyr-STAT3, relative to animals
treated with epinephrine alone, whereas pERK1/2 and pSer-STAT3
were unaffected (Fig. 2).
Table 1
NPD-α-MSH improves survival in rats subjected to CA/CPR and treated with
epinephrine.
Experimental group Treatment Survival rate at 3 h after CPR
Sham Saline 15/15 (100%)a
CA/CPR Saline 2/14 (14%)







CA¼Cardiac arrest; CPR¼Cardiopulmonary resuscitation; Sham¼sham CA/CPR;
Epinephrine (0.1 mg/kg, i.v.); NDP-α-MSH (340 μg/kg, i.v.).
a Po0.001 vs CA/CPRþsaline.
b Po0.05 vs CA/CPRþsaline.
c Po0.05 vs CA/CPRþepinephrine (Fisher's test).
A. Ottani et al. / European Journal of Pharmacology 745 (2014) 108–116110
3.4. NDP-α-MSH attenuates oxidative stress in the heart
To investigate CA/CPR-triggered oxidative stress in the left ven-
tricle, 3 h after CPR we evaluated MDA concentration (as an index of
oxidative stress-induced lipid peroxidation). In epinephrine-treated
rats we detected a higher concentration of MDA, as compared with
sham CA/CPR animals, whereas in CA/CPR rats treated with
epinephrine plus NDP-α-MSH there was a marked reduction (Fig. 3).
3.5. NDP-α-MSH attenuates inflammatory response in the heart
Next, we explored the myocardial CA/CPR-induced inflamma-
tory response by assessing the pro-inflammatory cytokines TNF-α
and IL-6, as well as the anti-inflammatory cytokine IL-10. At the
end of the 3 h period of return to spontaneous circulation,
immunoblot analysis showed that in the left ventricle of
epinephrine-treated rats there was a significant increase in TNF-
α and IL-6 levels, and a significant decrease in IL-10 expression, as
compared with sham CA/CPR animals (Fig. 4). In contrast, in CA/
CPR rats treated with epinephrine plus NDP-α-MSH there was a
marked reduction in TNF-α and IL-6 levels, whereas those of IL-10
increased (Fig. 4).
3.6. Apoptosis is not involved
Finally, at the end of the 3 h observation period, in the left
ventricle we investigated apoptosis by assessing expression of BAX
(that promotes apoptosis) and of the downstream executioner






















Basal                1 h  3 h
Fig. 1. Influence of NDP-α-MSH and epinephrine on mean arterial pressure (MAP)
and heart rate (HR) restoration in rats subjected to cardiac arrest (CA) followed by
cardiopulmonary resuscitation (CPR). Panel A: MAP in basal conditions, 1 h and 3 h
after CPR; panel B: HR in basal conditions, 1 h and 3 h after CPR. Mean values7S.E.
M. for 7–10 rats per group. Sham¼sham CA/CPR; S¼saline; E¼epinephrine
(0.1 mg/kg i.v., 1 min after starting CPR); NDP¼NDP-α-MSH (340 mg/kg i.v., 1 min
after starting CPR). *Po0.05, at least, vs. the same time point of CA/CPRþepinephr-
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Immunoblot analysis showed no difference between sham and
CA/CPR animals, irrespective of pharmacological treatment (Fig. 5).
4. Discussion
CA and CPR constitute a major problem both in- and out-of-
hospital (Chang et al., 2007; Nichol et al., 2008; Peberdy et al.,
2010; Rea et al., 2004; Thom et al., 2006). Routinely used
vasopressors (e.g., vasopressin, epinephrine, or their combination),
albeit have beneficial effects in the initial phase of CPR, exacerbate
myocardial ischemia/reperfusion injury and fail to significantly
improve survival and neurological outcome to hospital discharge
(Lin et al., 2014; Yu et al., 2013). Novel pharmacological
approaches able to ease CPR and also to minimize the general
adverse consequences of CA are, therefore, needed (Brücken et al.,
2014; Kida et al., 2012; Kurita et al., 2010; Lee et al., 2012; Norman
et al., 2011; Parnia et al., 2014; Yu et al., 2013).
Here we show that in a rat model of CA followed by CPR plus
epinephrine treatment, associated with significant free radical
discharge and inflammatory reaction in the left ventricle, meta-
bolic acidosis, hypotension, bradycardia and only 48% survival at
the end of the 3 h observation period, i.v. concomitant treatment
































































































































Fig. 2. Influence of NDP-α-MSH and epinephrine on the expression/activity of (A) janus kinases (pJAK/total JAK ratio), signal transducers and activators of transcription
(B) pTyr-STAT3 (pTyr-STAT3/total STAT3 ratio) and (C) pSer-STAT3 (pSer-STAT3/total STAT3 ratio), and extracellular signal-regulated kinases (pERK1/2/total ERK1/2 ratio), in
the left ventricle of rats subjected to cardiac arrest (CA) followed by cardiopulmonary resuscitation (CPR). The top of each panel shows representative immunoblots
highlighting expression/activity of the respective marker(s) and house-keeping gene product β-tubulin. Means values7S.E.M. for 7–10 rats per group, 3 h after CPR.
Sham¼sham CA/CPR; S¼saline; E¼epinephrine (0.1 mg/kg i.v., 1 min after starting CPR); NDP¼NDP-α-MSH (340 mg/kg i.v., 1 min after starting CPR). nPo0.05, at least, vs.
the corresponding value of CA/CPRþepinephrine (ANOVA followed by Student–Newman–Keuls test).
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completely restores the basal conditions of MAP and HR, reverses
hypoxemia and metabolic acidosis, induces left ventricle expres-
sion of the protective active transcription factors pJAK2 and pTyr-
STAT3, and improves survival rate. We also show that under NDP-
α-MSH treatment oxidative stress is diminished by melanocortin
treatment, as indicated by the reduced levels of MDA in the left
ventricle. Accordingly, melanocortins have been repeatedly
reported to reduce blood levels of oxygen-derived free radicals
and nitric oxide under pre-terminal conditions such as myocardial
ischemia/reperfusion, circulatory shock and respiratory arrest
(Giuliani et al., 2007a; Guarini et al., 1996, 1997a, 1997b, 1998;
Mioni et al., 2003, 2005), that could likewise contribute to prevent
organ damage in CA/CPR. The cardioprotective JAK/ERK/STAT
signaling pathways are also thought to supervise the transcrip-
tional regulation of several genes that modulate inflammation
(Bolli et al., 2011; de Jong et al., 2012; Minamino, 2012; Obana
et al., 2012; Ottani et al., 2013; Xuan et al., 2001, 2005). Consis-
tently, here we report that co-administration of epinephrine and
NDP-α-MSH also reduces heart levels of the pro-inflammatory
mediators TNF-α and IL-6, whereas increases those of the anti-
inflammatory cytokine IL-10. On the contrary, apoptosis is not
affected in our experimental model (probably because of the short
period of CA; see also below): indeed, no difference we found in
the expression of BAX and caspase-3 between sham and CA/CPR
animals, irrespective of pharmacological treatment.
We previously reported that melanocortins up-regulate expres-
sion of pERK1/2 in experimental models of myocardial ischemia/
reperfusion in Wistar rats (Mioni et al., 2005; Ottani et al., 2010,
2013). Surprisingly, in our experimental conditions of CA/CPR
(Sprague–Dawley, older rats), heart injury – irrespective of treat-
ment type – did not affect expression of pERK1/2, nor of pSer-
STAT3 (pERK1/2-dependent). These findings suggest that pERK1/2
might be involved as anti-apoptotic pro-survival kinases in patho-
physiological conditions different from CA/CPR, the discrepancy
maybe also depending on animal strain and age: consistently, in
our study we did not detect apoptotic response. Further, and
according to our present data, activation of the classic pro-survival
kinases ERK1/2, although considered important, is thought
not essential for cardioprotection against reperfusion-induced
damage, as demonstrated by using different models of animal
species, because alternative (STAT3-dependent) protective path-
ways exist (Lecour et al., 2005).
Obviously, our experimental model of CA/CPR is characterized
by a marked alterations of hemogasanalysis parameters. The
restored values of venous PO2 and SO2, here shown, indicate that
melanocortins are able to improve circulatory functions, and those
of PCO2, pH, HCO

3 and SBE reflect a reversal of metabolic acidosis,
according to previous studies carried out in other hypoxic condi-
tions such as circulatory shock (for review see: Giuliani et al., 2010,
2012). Of interest, lactate levels markedly increase only during CA
(Kurita et al., 2010), and normal blood concentration is usually
reached within 1 h after return to spontaneous circulation, in
agreement with our present results. Significant changes of Hct,
and electrolyte blood levels such as Naþ and Ca2þ , did not occur in
our CA/CPR model; on the contrary, Kþ concentration increased in
CA/CPR rats treated with epinephrine alone (seemingly due to KCl
injection), and the capability of NDP-α-MSH to restore Kþ level
could reflect a preservation of renal function.
Overall, our results – obtained by evaluating return to sponta-
neous circulation, survival, hemogasanalysis parameters, oxidative

























Fig. 3. Influence of NDP-α-MSH and epinephrine on malondialdeyde (MDA) levels
in the left ventricle of rats subjected to cardiac arrest (CA) followed by cardiopul-
monary resuscitation (CPR). Mean values7S.E.M. for 6 rats per group, 3 h after CPR.
Sham¼sham CA/CPR; S¼saline; E¼epinephrine (0.1 mg/kg i.v., 1 min after starting
CPR); NDP¼NDP-α-MSH (340 mg/kg i.v., 1 min after starting CPR). nPo0.001 vs. CA/















































































Fig. 4. Influence of NDP-α-MSH and epinephrine on the expression of (A) tumor necrosis factor-α (TNF-α), (B) interleukin-6 (IL-6) and (C) IL-10, in the left ventricle of rats
subjected to cardiac arrest (CA) followed by cardiopulmonary resuscitation (CPR). The top of each panel shows representative immunoblots highlighting expression of the
respective marker and house-keeping gene product β-tubulin. Mean values7S.E.M. for 7–10 rats per group, 3 h after CPR. Sham¼sham CA/CPR;; S¼saline; E¼epinephrine
(0.1 mg/kg i.v., 1 min after starting CPR); NDP¼NDP-α-MSH (340 mg/kg i.v., 1 min after starting CPR). nPo0.01, at least, vs. the corresponding value of CA/CPRþepinephrine
(ANOVA followed by Student–Newman–Keuls test).
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CPR with a combination of epinephrine and NDP-α-MSH could be
cardioprotective and more effective than epinephrine alone. This is
in agreement with the idea that epinephrine may exacerbate CA/
CPR-induced heart dysfunction as a consequence of increased
myocardial oxygen demand (Lin et al., 2014; Yu et al., 2013).
Melanocortins have been shown to induce multi-organ protec-
tion in several experimental models of hypoxic conditions, includ-
ing circulatory shock, respiratory arrest, brain ischemia, myoc-
ardial ischemia and more, and many investigations (both past and
recent) suggest that these protective effects result from brain
melanocortin MC3/MC4 receptor-activated anti-inflammatory
mechanisms, mediated by the vagus nerve (Bazzani et al., 2002;
Bertolini et al., 1989; Getting et al., 2006; Giuliani et al., 2007a,
2007b, 2012; Guarini et al., 1997a; Mioni et al., 2003, 2005; Ottani
et al., 2010, 2013). Indeed, melanocortins pass the blood-brain
barrier in pharmacologically relevant concentration (Catania et al.,
2004; Giuliani et al., 2012), and in previous studies with experi-
mental models of short-term and prolonged myocardial ischemia/
reperfusion we demonstrated that melanocortins induce cardio-
protection through a brain activation of an efferent vagal fibre-
mediated cholinergic anti-inflammatory pathway (Mioni
et al., 2005; Ottani et al., 2010). Noteworthy, the vagus nerve-
mediated cholinergic anti-inflammatory pathway – which is
thought to represent a rapid, self-defence neural mechanism,
and is activated by melanocortins (Giuliani et al., 2010, 2012;
Guarini et al., 2003; Mioni et al., 2005; Ottani et al., 2010; Tracey,
2002) – has been reported to inhibit macrophage inflammatory
responses in a mouse model of intestinal manipulation by activat-
ing the JAK2/STAT3 signaling (de Jonge et al., 2005). Further, in
mice it has been shown that CA/CPR impairs the cholinergic anti-
inflammatory pathway (Norman et al., 2011). Overall these find-
ings support our present data, and also suggest that in experi-
mental conditions of CA/CPR injury melanocortin-induced
molecular changes, including attenuation of free radical discharge
and inflammatory response, in the acute phase of the disease
likely play a key protective role not only in the heart, but also in
the brain, in agreement with the established neuroprotective
effects of melanocortin analogs (Gatti et al., 2012; Giuliani et al.,
2006, 2007b, 2009), and probably via activation of the cholinergic
anti-inflammatory pathway. On the basis of previous studies
performed in other hypoxic conditions (Giuliani et al., 2012), it
can be hypothesized that other organs could benefit from a
melanocortin treatment in CA/CPR.
It is well known that melanocortins modulate inflammatory
responses by down-regulating the expression of pro-inflammatory
mediators and by up-regulating that of anti-inflammatory factors,
including the potent anti-inflammatory cytokine IL-10 (Catania
et al., 2004; Giuliani et al., 2012), and IL-10 has been reported to
reduce heart damage in conditions of acute myocardial infarction via
activation of STAT3 (Frangogiannis, 2012; Krishnamurthy et al., 2009).
A growing body of evidence indicates that the anti-inflammatory/
cardioprotective effects of melanocortins are adrenal-independent
(Catania et al., 2004; Giuliani et al., 2010, 2012). In the present
investigation we used a melanocortin receptor agonist, NDP-α-MSH,
that binds melanocortin MC1, MC3, MC4 and MC5 receptors, but not
MC2 receptors, which are expressed in adrenal cortex and mediate
glucocorticoid release (Catania et al., 2004; Giuliani et al., 2012;
Wikberg and Mutulis, 2008); thus, an involvement of adrenal glands
can be ruled out also in the effects here reported. Further, on the basis
of our previous studies (Ottani et al., 2013), we rule out a direct
activation of STAT3. The multiple beneficial effects against CA/CPR
found in our present study, including activation of STAT3, might be
due to a physiologically arranged self-defence machinery that is
activated after melanocortin receptor-mediated signal transduction
of NDP-α-MSH, and that targets multiple CA/CPR-related pathophy-
siological pathways. Not even the anti-radical effect here shown can be
ascribed to a direct radical scavenging activity of melanocortins, as
previously demonstrated by competition experiments (reviewed by:
Giuliani et al., 2007a, 2010, 2012). Obviously, studies on the role of
specific melanocortin receptor subtypes in CA/CPR are useful, and we
have planned further research in this direction.
In conclusion, these results indicate that, in experimental
CA/CPR, melanocortins are able to improve return to spontaneous
























































Fig. 5. Influence of NDP-α-MSH and epinephrine on the expression of (A) BAX and (B) caspase-3 in the left ventricle of rats subjected to cardiac arrest (CA) followed by
cardiopulmonary resuscitation (CPR). The top of each panel shows representative immunoblots highlighting expression of the respective marker and house-keeping gene
product β-tubulin. Means values7S.E.M. for 7–10 rats per group, 3 h after CPR. Sham¼sham CA/CPR; S¼saline; E¼epinephrine (0.1 mg/kg i.v., 1 min after starting CPR);
NDP¼NDP-α-MSH (340 mg/kg i.v., 1 min after starting CPR). P40.05 among groups (ANOVA).
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radical discharge and inflammatory cascade, likely via activation of
the JAK2/STAT3 signaling pathway. Overall, these findings could
reflect a melanocortin-induced reduction of heart susceptibility to
ischemia/reperfusion injury, via JAK2/STAT3 signaling: indeed, the
JAK/STAT pathway plays an important role in pre- and post-
conditioning (Bolli et al., 2011; Obana et al., 2012; Xuan et al.,
2001). Moreover, melanocortins have established antipyretic
effects (Catania et al., 2004; Giuliani et al., 2012), that could be
clinically relevant: it is well known, in fact, that therapeutic
hypothermia has a protective action in CA/CPR (Lee et al., 2012).
Therefore, in CA/CPR conditions melanocortins, co-administered
with epinephrine, could be promising drugs for a treatment able to
rapidly improve cardiovascular function and tissue perfusion and
to block the main pathophysiological mechanisms of organ
damage. Further, melanocortins are devoid of appreciable toxicity
(Giuliani et al., 2012; Wikberg and Mutulis, 2008), and the
resuscitating and protective effects of melanocortin analogs in
experimental and clinical conditions of circulatory shock, myocar-
dial ischemia and cerebral ischemia have been recently high-
lighted to clinicians by Corander et al. (2009). The present
findings should encourage further studies – in particular long-
term studies are needed – because a treatment with melanocor-
tins plus epinephrine might represent a novel, safe and non-toxic
approach to the management of CA/CPR and consequent detri-
mental systemic responses, including neurological, renal, hepatic
and pulmonary dysfunctions.
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